A Study of the Perioperative Use of Cetuximab in Colon Cancer Patients.
Phase of Trial: Phase I
Latest Information Update: 18 May 2011
At a glance
- Drugs Cetuximab (Primary)
- Indications Colon cancer
- Focus Adverse reactions
- 18 May 2011 Status changed from recruiting to discontinued as reported by ClinicalTrials.gov.
- 15 Jun 2010 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.
- 05 Jul 2007 New trial record.